Abeona Therapeutics Inc.
corporate_fare Company Profile
Abeona Therapeutics Inc. (NASDAQ:ABEO) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for ABEO at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Shareholders to Vote on Significant Equity Plan Expansion and Governance Amendment
- Abeona Therapeutics Appoints Experienced Biotech CFO Keith Goldan to Board, Chairs Audit Committee
- Abeona Expands ZEVASKYN Access with New York Treatment Center Activation
- Abeona Therapeutics Amends Bylaws, Increases Shareholder Meeting Quorum to 50%
- Abeona Therapeutics Reports 2025 Annual Results, Driven by PRV Sale & ZEVASKYN Commercial Launch
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$5.82M
Net Income
$71.18M
Diluted EPS
$1.01
Op. Cash Flow
-$76.33M
Free Cash Flow
-$84.3M
Gross Profit
$4.29M
Operating Income
-$89.45M
Cash & Equivalents
$78.44M
Total Debt
$20.04M
Debt / Equity
0.13×
Net Margin
12.23×
Shares Outstanding
55.04M sh
Source: 10-K · filed 2026-03-17 · accession 0001493152-26-010413
show_chartPrice Chart
Loading chart...
feed ABEO - Filings & News (Page 2)
ABEO
Apr 17, 2026, 4:30 PM EDT
Price at Filing:
$5.50
Real-time Price:
$2.42
Change:
-$3.08 (-56%)
Market Cap:
$138.295M
ABEO
Apr 07, 2026, 8:35 AM EDT
Price at Filing:
$4.76
Real-time Price:
$2.42
Change:
-$2.34 (-49%)
Market Cap:
$138.295M
ABEO
Apr 02, 2026, 8:30 AM EDT
Price at Filing:
$4.58
Real-time Price:
$2.42
Change:
-$2.16 (-47%)
Market Cap:
$138.295M
ABEO
Mar 20, 2026, 4:30 PM EDT
Price at Filing:
$4.45
Real-time Price:
$2.42
Change:
-$2.03 (-46%)
Market Cap:
$138.295M
ABEO
Mar 17, 2026, 7:36 AM EDT
Price at Filing:
$4.88
Real-time Price:
$2.42
Change:
-$2.46 (-50%)
Market Cap:
$138.295M
ABEO
Mar 17, 2026, 7:30 AM EDT
Price at Filing:
$5.02
Real-time Price:
$2.42
Change:
-$2.60 (-52%)
Market Cap:
$138.295M
ABEO
Mar 09, 2026, 7:30 AM EDT
Price at Filing:
$4.85
Real-time Price:
$2.42
Change:
-$2.43 (-50%)
Market Cap:
$138.295M